Salvage radiotherapy for biochemical failure of radical prostatectomy: A single-institution experience

Stanley L. Liauw, W. Scott Webster, David A. Pistenmaa, Claus Roehrborn

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Objectives. To review the efficacy of salvage radiotherapy (RT), to treat elevated prostate-specific antigen (PSA) levels for presumed local recurrence of prostatic adenocarcinoma after retropubic prostatectomy, and identify the factors that may predict for successful treatment. Methods. Fifty-one patients with hormonally naive pT2-3N0-1M0 prostate cancer were treated with RT for locally persistent or recurrent disease. The patients received a median dose of 65.7 Gy (range 61.2 to 72.3) to the prostate bed. Successfully treated patients had undetectable PSA levels; the endpoint of the study was biochemical failure. Results. The median follow-up was 3.8 years; 42 of 51 patients had at least 2 years of follow-up. Twenty-three patients (45%) were biochemically free of disease. The estimated biochemically free of disease rate at 3 and 5 years was 56% and 16%, respectively. Whether the patients were treated for persistently elevated PSA levels or for rising PSA levels from undetectable levels after retropubic prostatectomy, their PSA values were equally likely to drop to undetectable levels (65%). Univariate analysis demonstrated two factors that significantly predicted for successful salvage treatment: the absence of seminal vesicle invasion and the absence of lymphovascular invasion. A pretreatment PSA level less than 0.425 ng/mL trended toward statistical significance (P = 0.059). Only seminal vesicle invasion maintained significance on multivariate analysis. The RT was well tolerated, and the gastrointestinal and genitourinary toxicity was largely Radiation Therapy Oncology Group grade 1. Conclusions. Salvage RT is moderately effective in treating patients with locally persistent or recurrent prostate adenocarcinoma. Seminal vesicle invasion and lymphovascular invasion predicted for unsuccessful treatment.

Original languageEnglish (US)
Pages (from-to)1204-1210
Number of pages7
JournalUrology
Volume61
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

Prostatectomy
Prostate-Specific Antigen
Radiotherapy
Seminal Vesicles
Prostate
Adenocarcinoma
Salvage Therapy
Radiation Oncology
Prostatic Neoplasms
Multivariate Analysis
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Salvage radiotherapy for biochemical failure of radical prostatectomy : A single-institution experience. / Liauw, Stanley L.; Webster, W. Scott; Pistenmaa, David A.; Roehrborn, Claus.

In: Urology, Vol. 61, No. 6, 01.06.2003, p. 1204-1210.

Research output: Contribution to journalArticle

Liauw, Stanley L. ; Webster, W. Scott ; Pistenmaa, David A. ; Roehrborn, Claus. / Salvage radiotherapy for biochemical failure of radical prostatectomy : A single-institution experience. In: Urology. 2003 ; Vol. 61, No. 6. pp. 1204-1210.
@article{74c6a6f8e3b94f08b1790be4ff2996e2,
title = "Salvage radiotherapy for biochemical failure of radical prostatectomy: A single-institution experience",
abstract = "Objectives. To review the efficacy of salvage radiotherapy (RT), to treat elevated prostate-specific antigen (PSA) levels for presumed local recurrence of prostatic adenocarcinoma after retropubic prostatectomy, and identify the factors that may predict for successful treatment. Methods. Fifty-one patients with hormonally naive pT2-3N0-1M0 prostate cancer were treated with RT for locally persistent or recurrent disease. The patients received a median dose of 65.7 Gy (range 61.2 to 72.3) to the prostate bed. Successfully treated patients had undetectable PSA levels; the endpoint of the study was biochemical failure. Results. The median follow-up was 3.8 years; 42 of 51 patients had at least 2 years of follow-up. Twenty-three patients (45{\%}) were biochemically free of disease. The estimated biochemically free of disease rate at 3 and 5 years was 56{\%} and 16{\%}, respectively. Whether the patients were treated for persistently elevated PSA levels or for rising PSA levels from undetectable levels after retropubic prostatectomy, their PSA values were equally likely to drop to undetectable levels (65{\%}). Univariate analysis demonstrated two factors that significantly predicted for successful salvage treatment: the absence of seminal vesicle invasion and the absence of lymphovascular invasion. A pretreatment PSA level less than 0.425 ng/mL trended toward statistical significance (P = 0.059). Only seminal vesicle invasion maintained significance on multivariate analysis. The RT was well tolerated, and the gastrointestinal and genitourinary toxicity was largely Radiation Therapy Oncology Group grade 1. Conclusions. Salvage RT is moderately effective in treating patients with locally persistent or recurrent prostate adenocarcinoma. Seminal vesicle invasion and lymphovascular invasion predicted for unsuccessful treatment.",
author = "Liauw, {Stanley L.} and Webster, {W. Scott} and Pistenmaa, {David A.} and Claus Roehrborn",
year = "2003",
month = "6",
day = "1",
doi = "10.1016/S0090-4295(03)00044-X",
language = "English (US)",
volume = "61",
pages = "1204--1210",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Salvage radiotherapy for biochemical failure of radical prostatectomy

T2 - A single-institution experience

AU - Liauw, Stanley L.

AU - Webster, W. Scott

AU - Pistenmaa, David A.

AU - Roehrborn, Claus

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Objectives. To review the efficacy of salvage radiotherapy (RT), to treat elevated prostate-specific antigen (PSA) levels for presumed local recurrence of prostatic adenocarcinoma after retropubic prostatectomy, and identify the factors that may predict for successful treatment. Methods. Fifty-one patients with hormonally naive pT2-3N0-1M0 prostate cancer were treated with RT for locally persistent or recurrent disease. The patients received a median dose of 65.7 Gy (range 61.2 to 72.3) to the prostate bed. Successfully treated patients had undetectable PSA levels; the endpoint of the study was biochemical failure. Results. The median follow-up was 3.8 years; 42 of 51 patients had at least 2 years of follow-up. Twenty-three patients (45%) were biochemically free of disease. The estimated biochemically free of disease rate at 3 and 5 years was 56% and 16%, respectively. Whether the patients were treated for persistently elevated PSA levels or for rising PSA levels from undetectable levels after retropubic prostatectomy, their PSA values were equally likely to drop to undetectable levels (65%). Univariate analysis demonstrated two factors that significantly predicted for successful salvage treatment: the absence of seminal vesicle invasion and the absence of lymphovascular invasion. A pretreatment PSA level less than 0.425 ng/mL trended toward statistical significance (P = 0.059). Only seminal vesicle invasion maintained significance on multivariate analysis. The RT was well tolerated, and the gastrointestinal and genitourinary toxicity was largely Radiation Therapy Oncology Group grade 1. Conclusions. Salvage RT is moderately effective in treating patients with locally persistent or recurrent prostate adenocarcinoma. Seminal vesicle invasion and lymphovascular invasion predicted for unsuccessful treatment.

AB - Objectives. To review the efficacy of salvage radiotherapy (RT), to treat elevated prostate-specific antigen (PSA) levels for presumed local recurrence of prostatic adenocarcinoma after retropubic prostatectomy, and identify the factors that may predict for successful treatment. Methods. Fifty-one patients with hormonally naive pT2-3N0-1M0 prostate cancer were treated with RT for locally persistent or recurrent disease. The patients received a median dose of 65.7 Gy (range 61.2 to 72.3) to the prostate bed. Successfully treated patients had undetectable PSA levels; the endpoint of the study was biochemical failure. Results. The median follow-up was 3.8 years; 42 of 51 patients had at least 2 years of follow-up. Twenty-three patients (45%) were biochemically free of disease. The estimated biochemically free of disease rate at 3 and 5 years was 56% and 16%, respectively. Whether the patients were treated for persistently elevated PSA levels or for rising PSA levels from undetectable levels after retropubic prostatectomy, their PSA values were equally likely to drop to undetectable levels (65%). Univariate analysis demonstrated two factors that significantly predicted for successful salvage treatment: the absence of seminal vesicle invasion and the absence of lymphovascular invasion. A pretreatment PSA level less than 0.425 ng/mL trended toward statistical significance (P = 0.059). Only seminal vesicle invasion maintained significance on multivariate analysis. The RT was well tolerated, and the gastrointestinal and genitourinary toxicity was largely Radiation Therapy Oncology Group grade 1. Conclusions. Salvage RT is moderately effective in treating patients with locally persistent or recurrent prostate adenocarcinoma. Seminal vesicle invasion and lymphovascular invasion predicted for unsuccessful treatment.

UR - http://www.scopus.com/inward/record.url?scp=0038277406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038277406&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(03)00044-X

DO - 10.1016/S0090-4295(03)00044-X

M3 - Article

C2 - 12809898

AN - SCOPUS:0038277406

VL - 61

SP - 1204

EP - 1210

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -